The latest closing stock price for Seres Therapeutics as of January 21, 2025 is 0.73.
An investor who bought $1,000 worth of Seres Therapeutics stock at the IPO in 2015 would have $-986 today, roughly -1 times their original investment - a -34.64% compound annual growth rate over 10 years.
The all-time high Seres Therapeutics stock closing price was 51.40 on June 26, 2015.
The Seres Therapeutics 52-week high stock price is 1.53, which is 109.6% above the current share price.
The Seres Therapeutics 52-week low stock price is 0.54, which is 26% below the current share price.
The average Seres Therapeutics stock price for the last 52 weeks is 0.91.
An investor who bought $1,000 worth of Seres Therapeutics stock at the IPO in 2015 would have $-986 today, roughly -1 times their original investment - a -34.64% compound annual growth rate over 10 years.
The all-time high Seres Therapeutics stock closing price was 51.40 on June 26, 2015.
The Seres Therapeutics 52-week high stock price is 1.53, which is 109.6% above the current share price.
The Seres Therapeutics 52-week low stock price is 0.54, which is 26% below the current share price.
The average Seres Therapeutics stock price for the last 52 weeks is 0.91.